Industry News
Protein regulation and intellectual disability
While many intellectual disabilities are caused directly by a genetic mutation in the protein coding part of genes, genetics researchers at the University of Adelaide have found a case where the cause is actually outside the gene, in the regulation of proteins. [ + ]
Birth of calf expected after ‘handmade cloning’
Professor Gábor Vajta has been working on a handmade cloning technique in collaboration with Australian Reproductive Technologies. [ + ]
Have you registered for biotech’s industry event of the year?
Prominent biotechnology individuals from across Australia and around the world will join the conference for agenda-setting programs, world-class networking and partnering opportunities, and over 150 industry-leading speakers in more than 30 sessions. [ + ]
Agenix opens new avenues with diagnostics deal
Agenix (ASX:AGX) has arranged to license a diagnostic device platform from Tyrian Diagnostics in a share swap deal. [ + ]
R&D Tax Incentive remains untouched as tax reform stalls
The government’s Business Tax Working Group has failed to reach agreement on how to fund a cut in corporate tax, leaving the R&D Tax Incentive as is. [ + ]
Destructive pea weevils on the way out
Farmers around the world are a step closer to eliminating the chemical spraying of field peas for the destructive pea weevil, thanks to research by agricultural scientists from The University of Western Australia (UWA). [ + ]
Opportunity to work with world-class scientists at summer school
Southern Cross University’s 2013 Science Summer School gives undergraduates or recent graduates the opportunity to team up with one of the university’s leading researchers to undertake a short science-based project over four weeks. [ + ]
Avexa's antibiotic storms lab tests
Avexa's (ASX:AVX) anti-bacterial compound AVX13616 has performed well in lab tests conducted by licensee Valevia Pharmaceuticals. [ + ]
Australian biotechs significantly outperforming ASX and Nasdaq
The Australian life science index is known for its volatility, but over the past decade it has outperformed the All Ordinaries and the Nasdaq by considerable margins. [ + ]
Are schizophrenia and autism close relations?
New research by Dr Mark Weiser of Tel Aviv University’s Sackler Faculty of Medicine and the Sheba Medical Center has revealed that ASD appears to share a root cause with other mental illnesses, including schizophrenia and bipolar disorder. [ + ]
Biota cleared to merge with Nabi
Biota Holdings (ASX:BTA) has been cleared to merge with Nabi Biopharmaceuticals after shareholders in both companies approved the deal. [ + ]
Generations: how cells inherit information
A new study has helped solve the problem of how epigenetic information is passed from one generation of cells to the next. [ + ]
Latest journal features AusBiotech 2012, tech transfer and more…
AusBiotech is pleased to announce that the bumper special edition of AusBiotech’s journal, Australasian Biotechnology, is now published, featuring a sneak peek at next week’s industry conference of the year, AusBiotech 2012, as well as a feature on tech transfer and biotechnology in Asia. [ + ]
Test strip earnings boost UBI revenue
Universal Biosensors (ASX:UBI) boosted its Q3 revenue by 50% and slashed its cash outflow, thanks to contributions from its two coagulation test strip partnerships. [ + ]
Government steadfast on research funding
The Australian Academy of Science has commended the government’s commitment to maintain funding for science research through the Australian Research Council (ARC) and Cooperative Research Centres (CRCs). [ + ]
